Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Melamed

Showing results (401-410 of 426) with videos related to

Pageof 43
Sort By:
Cancer|April 15, 1989
Check samples for laboratory self-assessment in DNA flow cytometry. The National Cancer Institute's Flow Cytometry Network experienceJ S Coon, A D Deitch, R W de Vere White, et al.
Cancer|January 1, 1988
Interinstitutional variability in DNA flow cytometric analysis of tumors. The National Cancer Institute's Flow Cytometry Network ExperienceJ S Coon, A D Deitch, R W de Vere White, et al.
Cytometry|January 1, 1991
Precision of DNA flow cytometry in inter-institutional analysesL L Wheeless, J S Coon, C Cox, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 21, 2021
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA deliveryJilian R Melamed, Khalid A Hajj, Namit Chaudhary, et al.
Science Advances|January 27, 2023
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transferJilian R Melamed, Saigopalakrishna S Yerneni, Mariah L Arral, et al.
Cytometry|November 1, 1989
Measurement variability in DNA flow cytometry of replicate samplesL L Wheeless, J S Coon, C Cox, et al.
Cytometry|November 1, 1988
Comparison of automated and manual techniques for analysis of DNA frequency distributions in bladder washingsL L Wheeless, J S Coon, A D Deitch, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 10, 2018
Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label studyIsaac R Melamed, Michael Borte, Laurenz Trawnicek, et al.
Journal of Clinical Immunology|November 16, 2022
BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in ChildrenGergely Kriván, Michael Borte, Pere Soler-Palacin, et al.
Journal of Clinical Immunology|July 30, 2017
Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label StudyMichael Borte, Isaac R Melamed, Grazyna Pulka, et al.
Pageof 43

Showing results (401-410 of 426) with videos related to

Sort By:
Pageof 43
Cancer|April 15, 1989
Check samples for laboratory self-assessment in DNA flow cytometry. The National Cancer Institute's Flow Cytometry Network experienceJ S Coon, A D Deitch, R W de Vere White, et al.
Cancer|January 1, 1988
Interinstitutional variability in DNA flow cytometric analysis of tumors. The National Cancer Institute's Flow Cytometry Network ExperienceJ S Coon, A D Deitch, R W de Vere White, et al.
Cytometry|January 1, 1991
Precision of DNA flow cytometry in inter-institutional analysesL L Wheeless, J S Coon, C Cox, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 21, 2021
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA deliveryJilian R Melamed, Khalid A Hajj, Namit Chaudhary, et al.
Science Advances|January 27, 2023
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transferJilian R Melamed, Saigopalakrishna S Yerneni, Mariah L Arral, et al.
Cytometry|November 1, 1989
Measurement variability in DNA flow cytometry of replicate samplesL L Wheeless, J S Coon, C Cox, et al.
Cytometry|November 1, 1988
Comparison of automated and manual techniques for analysis of DNA frequency distributions in bladder washingsL L Wheeless, J S Coon, A D Deitch, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 10, 2018
Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label studyIsaac R Melamed, Michael Borte, Laurenz Trawnicek, et al.
Journal of Clinical Immunology|November 16, 2022
BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in ChildrenGergely Kriván, Michael Borte, Pere Soler-Palacin, et al.
Journal of Clinical Immunology|July 30, 2017
Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label StudyMichael Borte, Isaac R Melamed, Grazyna Pulka, et al.
Pageof 43